CSIMarket
 


Kempharm, Inc  (KMPH)
Other Ticker:  
 
 

KMPH's Operating Income Growth by Quarter and Year

Kempharm, Inc's Operating Income results by quarter and year




KMPH Operating Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -9.27 -8.15 -10.84
III Quarter September - -17.96 -9.61 -10.40
II Quarter June -7.79 -13.91 -8.22 -9.28
I Quarter March -11.37 -14.77 -7.38 -6.97
FY   -19.16 -55.91 -33.36 -37.49



KMPH Operating Income second quarter 2019 Y/Y Growth Comment
Kempharm, Inc in the second quarter recorded Operating Loss of $ -7.79 millions.

According to the results reported in the second quarter, Kempharm, Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Kempharm, Inc' s Operating Income no change of % ranks overall at the positon no. in the second quarter.

Explain Operating Income growth


KMPH Operating Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Kempharm, Inc's second quarter 2019 Operating Income $ -7.79 millions KMPH's Income Statement
Kempharm, Inc's second quarter 2018 Operating Income $ -13.91 millions Quarterly KMPH's Income Statement
New: More KMPH's historic Operating Income Growth >>


KMPH Operating Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Kempharm, Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's II. Quarter Q/Q Operating Income Comment
Even if Kempharm, Inc in the II. Quarter 2019 revealed Operating Loss of $ -7.79 millions, some analyst mentioned, that current results point to slight up side compare to the -11.37 millions in the first quarter.

Within Major Pharmaceutical Preparations industry Kempharm, Inc achieved highest sequential Operating Income growth. While Kempharm, Inc's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's II. Quarter Q/Q Operating Income Comment
Despite the fact, that Kempharm, Inc in the II. Quarter 2019 showed Operating Loss of $ -7.79 millions, management mentioned, that those numbers show slight up side compare to the -11.37 millions in the first quarter.

Within Major Pharmaceutical Preparations industry Kempharm, Inc achieved highest sequential Operating Income growth. While Kempharm, Inc's Operating Income growth quarter on quarter, overall rank is .


Kempharm, Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Operating Income 12 Months Ending $ -46.39 $ -52.50 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Kempharm, Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Kempharm, Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
KMPH's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for KMPH's Competitors
Operating Income Growth for Kempharm, Inc's Suppliers
Operating Income Growth for KMPH's Customers

You may also want to know
KMPH's Annual Growth Rates KMPH's Profitability Ratios KMPH's Asset Turnover Ratio KMPH's Dividend Growth
KMPH's Roe KMPH's Valuation Ratios KMPH's Financial Strength Ratios KMPH's Dividend Payout Ratio
KMPH's Roa KMPH's Inventory Turnover Ratio KMPH's Growth Rates KMPH's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Jun 30 2019
Prestige Consumer Healthcare Inc. -1.38 %$ -1.381 millions
Boston Scientific Corporation -2.04 %$ -2.041 millions
Neubase Therapeutics, Inc. -2.52 %$ -2.521 millions
Atrion Corp -2.66 %$ -2.663 millions
Tenax Therapeutics, Inc. -3.66 %$ -3.664 millions
Tenet Healthcare Corp -4.43 %$ -4.433 millions
Zynex Inc -4.83 %$ -4.825 millions
Orasure Technologies Inc -4.91 %$ -4.912 millions
Molecular Templates, Inc. -6.11 %$ -6.112 millions
Electromed, Inc. -6.62 %$ -6.621 millions
Baxter International Inc -7.55 %$ -7.552 millions
Integrated Biopharma Inc -8.00 %$ -8.000 millions
Stryker Corp -8.78 %$ -8.780 millions
Laboratory Corp Of America Holdings -9.07 %$ -9.074 millions
Hill-rom Holdings, Inc. -10.96 %$ -10.955 millions
Icu Medical Inc -12.44 %$ -12.438 millions
Inogen Inc -13.38 %$ -13.380 millions
Acadia Healthcare Company, Inc. -13.65 %$ -13.649 millions
Diffusion Pharmaceuticals Inc. -14.85 %$ -14.853 millions
National Healthcare Corp -16.24 %$ -16.243 millions
Merit Medical Systems Inc -19.27 %$ -19.274 millions
Pacira Biosciences, Inc. -19.35 %$ -19.355 millions
Henry Schein, Inc. -19.40 %$ -19.400 millions
Pacific Health Care Organization Inc -23.51 %$ -23.511 millions
Meridian Bioscience Inc -26.00 %$ -25.999 millions
Cambrex Corp -26.33 %$ -26.335 millions
Endo International Plc -27.93 %$ -27.928 millions
Biolife Solutions Inc -28.47 %$ -28.470 millions
Zimmer Biomet Holdings, Inc. -30.84 %$ -30.845 millions
Healthcare Services Group Inc -32.45 %$ -32.448 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ATXI's Profile

Stock Price

ATXI's Financials

Business Description

Fundamentals

Charts & Quotes

ATXI's News

Suppliers

ATXI's Competitors

Customers & Markets

Economic Indicators

ATXI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071